Cargando…
Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antiretroviral treatment are related to assay variation and/or increased sensitivity of new commercial assays. The 50-copy cut-off for virologic failure is, therefore, under debate. METHODS: Treated patient...
Autores principales: | Hofstra, Laura Marije, Mudrikova, Tania, Stam, Arjen J., Otto, Sigrid, Tesselaar, Kiki, Nijhuis, Monique, Wensing, Annemarie M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212971/ https://www.ncbi.nlm.nih.gov/pubmed/25354368 http://dx.doi.org/10.1371/journal.pone.0110749 |
Ejemplares similares
-
Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses
por: Marije Hofstra, Laura, et al.
Publicado: (2014) -
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
por: Widera, Marek, et al.
Publicado: (2017) -
Residual Viremia in Treated HIV(+) Individuals
por: Conway, Jessica M., et al.
Publicado: (2016) -
Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022) -
Bocavirus viremia
por: Sukkaromdee, Pathoom, et al.
Publicado: (2015)